Listen for Questions About Meds to Prevent RSV in Young Children
October 2023
Nirsevimab-alip (Beyfortus) will be a new med to prevent respiratory syncytial virus (RSV) in young children.
You’ll hear nirsevimab called a vaccine...since it’s an intramuscular (IM) injection that provides protection against RSV. But it’s a monoclonal antibody that’s given in a clinic or hospital.
Nirsevimab joins palivizumab (Synagis)...another injectable monoclonal antibody to prevent serious illness from RSV.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote